Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring.
Simon Lebech CichoszMorten Hasselstrøm JensenSøren Schou OlesenPublished in: Diabetes technology & therapeutics (2024)
Aim: The aim of this study was to develop and validate a prediction model based on continuous glucose monitoring (CGM) data to identify a week-to-week risk profile of excessive hypoglycemia. Methods: We analyzed, trained, and internally tested two prediction models using CGM data from 205 type 1 diabetes patients with long-term CGM monitoring. A binary classification approach (XGBoost) combined with feature engineering deployed on the CGM signals was utilized to predict excessive hypoglycemia risk defined by two targets (time below range [TBR] >4% and the upper TBR 90th percentile limit) of TBR the following week. The models were validated in two independent cohorts with a total of 253 additional patients. Results: A total of 61,470 weeks of CGM data were included in the analysis. The XGBoost models had an area under the receiver operating characteristic curve (ROC-AUC) of 0.83-0.87 (95% confidence interval; 0.83-0.88) in the test dataset. The external validation showed ROC-AUCs of 0.81-0.90. The most discriminative features included the low blood glucose index, the glycemic risk assessment diabetes equation (GRADE), hypoglycemia, the TBR, waveform length, the coefficient of variation and mean glucose during the previous week. This highlights that the pattern of hypoglycemia combined with glucose variability during the past week contains information on the risk of future hypoglycemia. Conclusion: Prediction models based on real-world CGM data can be used to predict the risk of hypoglycemia in the forthcoming week. The models showed good performance in both the internal and external validation cohorts.
Keyphrases
- type diabetes
- glycemic control
- blood glucose
- machine learning
- big data
- electronic health record
- risk assessment
- cardiovascular disease
- weight loss
- insulin resistance
- end stage renal disease
- deep learning
- placebo controlled
- chronic kidney disease
- randomized controlled trial
- ejection fraction
- newly diagnosed
- data analysis
- magnetic resonance imaging
- weight gain
- clinical trial
- blood pressure
- healthcare
- body mass index
- metabolic syndrome
- climate change
- heavy metals
- computed tomography
- human health
- social media
- preterm birth
- breast cancer risk